Adaptive Biotechnologies (ADPT) EBT Growth (1y) (2019 - 2026)
Adaptive Biotechnologies (ADPT) EBT Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -161.54% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 7.04% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 9.39% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 14.63% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 56.92% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -27.03% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 1.55% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -13.74% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.82% |
| 10 | Adaptive Biotechnologies | 2.71 Bn | 2.50 Bn | 52.17 Mn | 32.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.90% |
| Dec 31, 2025 | 59.73% |
| Sep 30, 2025 | 129.74% |
| Jun 30, 2025 | 44.66% |
| Mar 31, 2025 | 37.24% |
| Dec 31, 2024 | 51.46% |
| Sep 30, 2024 | 36.22% |
| Jun 30, 2024 | 3.27% |
| Mar 31, 2024 | 17.62% |
| Dec 31, 2023 | -72.94% |
| Sep 30, 2023 | -11.05% |
| Jun 30, 2023 | 8.20% |
| Mar 31, 2023 | 8.12% |
| Dec 31, 2022 | 34.53% |
| Sep 30, 2022 | 19.07% |
| Jun 30, 2022 | -5.64% |
| Mar 31, 2022 | -54.51% |
| Dec 31, 2021 | -41.20% |
| Sep 30, 2021 | -55.42% |
| Jun 30, 2021 | -40.80% |